COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2019
16/04/2019
Company Announcement Net sales of DARZALEX in the first quarter of 2019 totaled USD 629 million Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; April 16, 2019 – Genmab A/ [...]
Emergent BioSolutions Announces Interim Results From Phase 2 Study Evaluating CHIKV-VLP, Chikungunya Virus Vaccine Candidate
16/04/2019
GAITHERSBURG, Md., April 16, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced results from the interim analysis of its Phase 2 clinical study evaluating the safety and immunogenicity of the [...]
FDA Agrees to Rolling Review of Mesoblast’s Biologics License Application for Its Cell Therapy in Children With Steroid-Refractory Acute Graft Versus Host Disease
16/04/2019
NEW YORK and MELBOURNE, Australia, April 16, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) global leader in cellular medicines for inflammatory diseases, announced today that the United States Food [...]
ContraFect Presents Additional Positive Data from the Phase 2 Trial of Exebacase at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
16/04/2019
New data include secondary endpoint analyses of clinical responder rates at Day 7, End of Treatment, and Test of Cure, and pre-specified analyses of the clinical responder rates by final diagnosis at Day 14 New MRSA [...]
Corrections to the Latvian version of the news about 3 month results - corrections made only in the list of countries in the table: Unconsolidated sales – March and 3 months
16/04/2019
Corrections have been made only to the Latvian version of the news. Corrections made only in the list of the countries, mentioned in the tables: Unconsolidated sales - March and 3 months. The textual information didn't [...]
Invitation to Q1 conference call
16/04/2019
Oslo, Norway, 16 April 2019 Vistin Pharma ASA will release its first quarter 2019 results on Thursday 25 April 2019. Vistin Pharma will host a conference call for all shareholders and interested parties on 25 April at [...]
Olainfarm appoints new contact for investor relations – Jānis Dubrovskis
16/04/2019
JSC Olainfarm hereby informs that from now on, Investor Relations Advisor Jānis Dubrovskis will be the core contact person for shareholders and investors. The contact details of Jānis Dubrovskis are the following: [...]
SPINEWAY : Souscription de 150 OCEANE
16/04/2019
Communiqué de presse, Ecully le 16 avril 2019. Souscription d’une tranche de 150 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d’actions pour [...]
Olainfarm Group sales increase by 14% in Q1 2019
16/04/2019
Consolidated sales – March and 3 months Preliminary consolidated results of JSC Olainfarm for March 2019, show that the Group has made sales worth 10.8 million euros, which represents an increase by 3% compared to March [...]
C-RAD meddelar att teckningsoptioner har utnyttjats och att tilldelning av aktier skett
16/04/2019
C-RAD AB (publ) ("C-RAD" eller "Bolaget") meddelar att 264 000 teckningsoptioner som emitterades efter beslut av årsstämman den 14 april 2016 har utnyttjats av innehavare till en kurs om 11,80 kronor och att styrelsen [...]
Motif Bio Presents New Iclaprim Data at ECCMID 2019
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, announced today that new iclaprim data are being [...]
Helix BioPharma Corp. Reports Voting Results
16/04/2019
RICHMOND HILL, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]
Canada House Wellness Group Welcomes Gaetan Lussier and Shawn Graham to its Board of Directors
16/04/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”) is [...]
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
16/04/2019
U.S. Food and Drug Administration has completed its review and determined that the study may proceed LA JOLLA, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the [...]
NILE Study Results Demonstrating Guardant360’s High Concordance to Tissue Testing in Advanced NSCLC Published in Clinical Cancer Research
15/04/2019
REDWOOD CITY, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that the positive results from the NILE study, a head-to-head comparison of the Guardant360® assay to standard-of- [...]
Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA™ (Omadacycline) with New ECCMID 2019 Data Presentations
15/04/2019
- New microbiology data reinforce activity of NUZYRA against broad range of pathogens commonly associated with community-acquired infections - Study supports no dose adjustments in patients based on BMI AMSTERDAM, The [...]
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15/04/2019
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Globus Medical Launches FORTIFY Variable Angle Expandable Corpectomy Spacer System
15/04/2019
Continuing the Advancement in Spine Surgery with Expandable Technology Solutions AUDUBON, Pa., April 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today [...]
Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy
15/04/2019
CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced three oral presentations at the 22 nd Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), [...]

Pages